{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"combined-immunodeficiency-with-skin-granulomas","columns":[{"gene":"","key":"population-a2b2ec60eb33815d5b91","label":"Combined cellular and humoral immune defects with granulomas","mondoId":"MONDO:0009306","onsetQualifier":null,"originColumnKey":"MONDO:0009306/OMIM:233650","originalViews":[{"key":"MONDO:0009306/OMIM:233650","label":"Combined cellular and humoral immune defects with granulomas","scopeLabel":"OMIM:233650","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["054396fa643cef80113c6e50abeed98e6be067f4ee3e9444775b86976b49fb65","2669c872facab655b80abf4a0992bf9001ec2a84fb64471d8ad497eca82947c6","4259190e7d34fecee3d2d3f96e3bdf786b3307a57d712f998135134a53a58eb5","8eea6e57b3c78554871f2c31d86d8f5687da473242b0db7b57228d2f6c43a8c4","c90ee22ce76f6bca70910b565c1c5f9e260cfa7037ae16c37ad88fbed7e5bcfa"],"recordQualifiers":{},"scopeLabel":"OMIM:233650","sourceIds":["OMIM:233650"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-a2b2ec60eb33815d5b91"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0005387","HP:0004315","HP:0010976","HP:0005403","HP:0002205"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":5,"sourceGroups":{"omim":5}},"features":[{"hpoId":"HP:0005387","label":"Combined immunodeficiency","primary":true},{"hpoId":"HP:0004315","label":"Decreased circulating IgG concentration","primary":true},{"hpoId":"HP:0010976","label":"Decreased total B cell count","primary":true},{"hpoId":"HP:0005403","label":"Decreased total T cell count","primary":true},{"hpoId":"HP:0002205","label":"Recurrent respiratory infections","primary":true}],"ledeHtml":"Combined immunodeficiency with granulomatosis is characterized by recurrent viral infections and the presence of granulomas in the skin, mucous membranes and/or internal organs. There is a gradual reduction in the number and function of B cells (a type of white blood cell that makes antibodies), and T lymphocytes (a type of white blood cell, that protect the body from infection attacking the infected cells directly), hypogammaglobulinemia (reduction in all types of gamma globulins, including antibodies that help fight infection.) and defective autoinmunity where the immune system attacks the body itself. Some people may develop associated auto-immune diseases such as myasthenia gravis, vitiligo, low blood red and white cells, psoriasis, and Guillain-Barré syndrome. It is caused by genetic changes in the RAG1 and/or RAG2 genes. These genes provide instructions for making a member of a group of proteins called the RAG complex, which is involved in the process, known as V(D)J recombination, needed for maintaining the diversity of the B and T cells so they can be able to recognize diverse foreign agents allowing the body to fight infections. The genetic changes can impair RAG complex formation and function, resulting in an impaired B and T cells&#x27; function. Depending on the residual activity of the RAG proteins the disease can be more or less severe. In less severe cases symptoms are milder and may appear later in life.","mondoId":"MONDO:0009306","node":{"canonicalSlug":"combined-immunodeficiency-with-skin-granulomas","comparisons":[{"documentSha256":"7526c4c9979e42088cc895baffc84e331be84981cca8388523fcbb883642b5c5","key":"legacy-combined-immunodeficiency-with-skin-granulomas","kind":"legacy","label":"combined immunodeficiency with skin granulomas","memberIds":["MONDO:0009306"],"mondoId":"MONDO:0009306","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/combined-immunodeficiency-with-skin-granulomas.7526c4c9979e42088cc895baffc84e331be84981cca8388523fcbb883642b5c5.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"summary","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Combined immunodeficiency with skin granulomas","originalSourceId":"ORPHA:157949","paragraphs":["Combined immunodeficiency with granulomatosis is characterized by recurrent viral infections and the presence of granulomas in the skin, mucous membranes and/or internal organs. There is a gradual reduction in the number and function of B cells (a type of white blood cell that makes antibodies), and T lymphocytes (a type of white blood cell, that protect the body from infection attacking the infected cells directly), hypogammaglobulinemia (reduction in all types of gamma globulins, including antibodies that help fight infection.) and defective autoinmunity where the immune system attacks the body itself. Some people may develop associated auto-immune diseases such as myasthenia gravis, vitiligo, low blood red and white cells, psoriasis, and Guillain-Barré syndrome. It is caused by genetic changes in the RAG1 and/or RAG2 genes. These genes provide instructions for making a member of a group of proteins called the RAG complex, which is involved in the process, known as V(D)J recombination, needed for maintaining the diversity of the B and T cells so they can be able to recognize diverse foreign agents allowing the body to fight infections. The genetic changes can impair RAG complex formation and function, resulting in an impaired B and T cells' function. Depending on the residual activity of the RAG proteins the disease can be more or less severe. In less severe cases symptoms are milder and may appear later in life."],"rawAttribution":"GARD:0013587","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:00:37Z","upstream":"PlainLanguagePilotV1-Sep23","url":"https://rarediseases.info.nih.gov/diseases/13587"},"ownColumnKeys":["population-a2b2ec60eb33815d5b91"],"publication":"published","relationships":[{"kind":"parent","label":"T-B- severe combined immunodeficiency","mondoId":"MONDO:0017855","slug":"t-b-severe-combined-immunodeficiency"},{"kind":"parent","label":"hereditary skin disorder","mondoId":"MONDO:0100118","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"reported","key":"054396fa643cef80113c6e50abeed98e6be067f4ee3e9444775b86976b49fb65","raw":{"aspect":"P","body_system":"respiratory","disease_id":"OMIM:233650","disease_name":"Combined cellular and humoral immune defects with granulomas","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002205","is_excluded":false,"label":"Recurrent respiratory infections","onset_id":null,"reference":"OMIM:233650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"2669c872facab655b80abf4a0992bf9001ec2a84fb64471d8ad497eca82947c6","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:233650","disease_name":"Combined cellular and humoral immune defects with granulomas","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0005387","is_excluded":false,"label":"Combined immunodeficiency","onset_id":null,"reference":"OMIM:233650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4259190e7d34fecee3d2d3f96e3bdf786b3307a57d712f998135134a53a58eb5","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:233650","disease_name":"Combined cellular and humoral immune defects with granulomas","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0010976","is_excluded":false,"label":"Decreased total B cell count","onset_id":null,"reference":"OMIM:233650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"8eea6e57b3c78554871f2c31d86d8f5687da473242b0db7b57228d2f6c43a8c4","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:233650","disease_name":"Combined cellular and humoral immune defects with granulomas","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0005403","is_excluded":false,"label":"Decreased total T cell count","onset_id":null,"reference":"OMIM:233650","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"c90ee22ce76f6bca70910b565c1c5f9e260cfa7037ae16c37ad88fbed7e5bcfa","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:233650","disease_name":"Combined cellular and humoral immune defects with granulomas","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004315","is_excluded":false,"label":"Decreased circulating IgG concentration","onset_id":null,"reference":"OMIM:233650","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/13587\" rel=\"noreferrer\">GARD</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>PlainLanguagePilotV1-Sep23</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Combined immunodeficiency with granulomatosis is characterized by recurrent viral infections and the presence of granulomas in the skin, mucous membranes and/or internal organs. There is a gradual reduction in the number and function of B cells (a type of white blood cell that makes antibodies), and T lymphocytes (a type of white blood cell, that protect the body from infection attacking the infected cells directly), hypogammaglobulinemia (reduction in all types of gamma globulins, including antibodies that help fight infection.) and defective autoinmunity where the immune system attacks the body itself. Some people may develop associated auto-immune diseases such as myasthenia gravis, vitiligo, low blood red and white cells, psoriasis, and Guillain-Barré syndrome. It is caused by genetic changes in the RAG1 and/or RAG2 genes. These genes provide instructions for making a member of a group of proteins called the RAG complex, which is involved in the process, known as V(D)J recombination, needed for maintaining the diversity of the B and T cells so they can be able to recognize diverse foreign agents allowing the body to fight infections. The genetic changes can impair RAG complex formation and function, resulting in an impaired B and T cells&#x27; function. Depending on the residual activity of the RAG proteins the disease can be more or less severe. In less severe cases symptoms are milder and may appear later in life.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/13587\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Overview"}],"sharedSources":[],"slug":"combined-immunodeficiency-with-skin-granulomas","sourceDocuments":[{"name":"GARD: Combined immunodeficiency with skin granulomas","reviewed":null,"source_release":"2026-10-21T17:00:37Z","url":"https://rarediseases.info.nih.gov/diseases/13587"}],"sourceNote":"","synonyms":["CCHIDG","CID due to RAG 1/2 deficiency","combined cellular and humoral immune defects with granulomas","combined immunodeficiency due to RAG 1/2 deficiency"],"takeawayHtml":"","title":"combined immunodeficiency with skin granulomas"},"schemaVersion":1}
